| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
JPAG - PAST MEETINGS
RETURN TO MEETINGS
Thursday 25th March 2021
Stability V: Challenges of in-use stability demonstration
VIRTUAL EVENT : 1pm-4pm (UK GMT)
Continuing our successful series of stability meetings, this event is essential for anyone concerned with the management and assessment of drug stability in-use. We have a group of expert speakers on in-use stability topics from the regulator, the industry and the NHS end user to give a background of their in-use stability perspectives and provide examples of practical issues they have had to face in their every day work.
• Hear about the regulation of in-use stability.
• Learn from industry experts about the challenges they face to meet in-use stability regulations with case studies
• Examine ways the NHS has to work with this data in the "real world" setting and learn about the NHS standards
The meeting will continue with the speakers forming a workshop style panel to debate a selection of hypothetical examples, practical issues, compliance and many more nuances of the in-use stability topic.
Speakers:
Miles Ambler - GlaxoSmithKline
Bridget Bulwer - Glycostem
Dr Laura Davies - Newcastle upon Tyne Hospitals NHS Foundation Trust
Dr Paul Marshall - Jazz Pharmaceuticals
Stability V: Challenges of in-use stability demonstration
VIRTUAL EVENT : 1pm-4pm (UK GMT)
Continuing our successful series of stability meetings, this event is essential for anyone concerned with the management and assessment of drug stability in-use. We have a group of expert speakers on in-use stability topics from the regulator, the industry and the NHS end user to give a background of their in-use stability perspectives and provide examples of practical issues they have had to face in their every day work.
• Hear about the regulation of in-use stability.
• Learn from industry experts about the challenges they face to meet in-use stability regulations with case studies
• Examine ways the NHS has to work with this data in the "real world" setting and learn about the NHS standards
The meeting will continue with the speakers forming a workshop style panel to debate a selection of hypothetical examples, practical issues, compliance and many more nuances of the in-use stability topic.
Speakers:
Miles Ambler - GlaxoSmithKline
Bridget Bulwer - Glycostem
Dr Laura Davies - Newcastle upon Tyne Hospitals NHS Foundation Trust
Dr Paul Marshall - Jazz Pharmaceuticals
RETURN TO MEETINGS
WANT TO SEE MORE?
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
You will have access to materials for meetings that you have attended.
You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.
PAST MEETINGS
Symposium - October 2011
Delegates at a symposium held at the Royal Pharmaceutical Society
| Call us: | CONTACT US | Follow us: |     | Terms and Conditions Privacy Statement |
| Joint Pharmaceutical Analysis Group 2025 Website © and by Delta Consultancy Services |
|